TY - JOUR
T1 - Staging dementia using clinical dementia rating scale sum of boxes scores
T2 - A Texas Alzheimer's research consortium study
AU - O'Bryant, Sid E.
AU - Waring, Stephen C.
AU - Cullum, C. Munro
AU - Hall, James
AU - Lacritz, Laura
AU - Massman, Paul J.
AU - Lupo, Philip J.
AU - Reisch, Joan S.
AU - Doody, Rachelle
PY - 2008/8
Y1 - 2008/8
N2 - Background: The Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) score is commonly used, although the utility regarding this score in staging dementia severity is not well established. Objective: To investigate the effectiveness of CDR-SOB scores in staging dementia severity compared with the global CDR score. Design: Retrospective study. Setting: Texas Alzheimer's Research Consortium minimum data set cohort. Participants: A total of 1577 participants (110 controls, 202 patients with mild cognitive impairment, and 1265 patients with probable Alzheimer disease) were available for analysis. Main Outcome Measures: Receiver operating characteristic curves were generated from a derivation sample to determine optimal cutoff scores and ranges, which were then applied to the validation sample. Results: Optimal ranges of CDR-SOB scores corresponding to the global CDR scores were 0.5 to 4.0 for a global score of 0.5, 4.5 to 9.0 for a global score of 1.0, 9.5 to 15.5 for a global score of 2.0, and 16.0 to 18.0 for a global score of 3.0. When applied to the validation sample, κ scores ranged from 0.86 to 0.94 (P < .001 for all), with 93.0% of the participants falling within the new staging categories. Conclusions: The CDR-SOB score compares well with the global CDR score for dementia staging. Owing to the increased range of values, the CDR-SOB score offers several advantages over the global score, including increased utility in tracking changes within and between stages of dementia severity. Interpretive guidelines for CDR-SOB scores are provided.
AB - Background: The Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) score is commonly used, although the utility regarding this score in staging dementia severity is not well established. Objective: To investigate the effectiveness of CDR-SOB scores in staging dementia severity compared with the global CDR score. Design: Retrospective study. Setting: Texas Alzheimer's Research Consortium minimum data set cohort. Participants: A total of 1577 participants (110 controls, 202 patients with mild cognitive impairment, and 1265 patients with probable Alzheimer disease) were available for analysis. Main Outcome Measures: Receiver operating characteristic curves were generated from a derivation sample to determine optimal cutoff scores and ranges, which were then applied to the validation sample. Results: Optimal ranges of CDR-SOB scores corresponding to the global CDR scores were 0.5 to 4.0 for a global score of 0.5, 4.5 to 9.0 for a global score of 1.0, 9.5 to 15.5 for a global score of 2.0, and 16.0 to 18.0 for a global score of 3.0. When applied to the validation sample, κ scores ranged from 0.86 to 0.94 (P < .001 for all), with 93.0% of the participants falling within the new staging categories. Conclusions: The CDR-SOB score compares well with the global CDR score for dementia staging. Owing to the increased range of values, the CDR-SOB score offers several advantages over the global score, including increased utility in tracking changes within and between stages of dementia severity. Interpretive guidelines for CDR-SOB scores are provided.
UR - http://www.scopus.com/inward/record.url?scp=49449099715&partnerID=8YFLogxK
U2 - 10.1001/archneur.65.8.1091
DO - 10.1001/archneur.65.8.1091
M3 - Article
C2 - 18695059
AN - SCOPUS:49449099715
SN - 0003-9942
VL - 65
SP - 1091
EP - 1095
JO - Archives of Neurology
JF - Archives of Neurology
IS - 8
ER -